| http://www.w3.org/ns/prov#value | - Through this move, Biovitrum aims at developing its therapeutic area base - which includes metabolic diseases such as type 2 diabetes and obesity as well as specialty indications such as onco logy and ophtalmology - and advancing its product portfolio, aiming at strengthening its position as a leading European player.
|
